Skip to content
Fullscript leaf logo
Create account
Fullscript logo
Fullscript leaf logo
  • Solutions
    • Plan care
      Lab testing Offer end-to-end diagnostics.
      Supplement catalog Recommend healthcare’s best.
      Clinical decision support Optimize your patients’ plans.
      Evidence-based templates Build complete plans quickly.
    • Deliver care
      Online plans Send individual and multi-patient plans.
      Wholesale ordering Dispense supplements from your clinic.
    • Engage patients
      Patient experience See how patients thrive on Fullscript.
      Adherence & insights Keep patients on track with less effort.
      Patient promotions Offer savings, engage patients in a few clicks.
    • IntegrationsSee all integrations
  • Resources
    • Learn
      How to use Fullscript Explore quick demos, articles, and more.
      Wellness blog Education for practitioners and patients.
      Webinars 100+ recordings of practitioner discussions.
      Protocols Our library of evidence-based protocols.
      Clinical evidence Studies that support the Fullscript platform.
      Practice resources Handouts, promotional tools, and more.
      Ingredient library Decision support for supplement ingredients.
    • Featured
      lets make healthcare whole kyle feature image
      Let’s Make Healthcare Whole

      Learn how Fullscript is making whole person care more attainable, scalable, and impactful.

  • Pricing
Sign in Create account Book a demo Sign in
Conditions
—

What is Hyperandrogenism?

April 12, 2022
Fact checked
Written by Jayelah Bush, BScN
Medically reviewed by
Dr. Peter Woznik, ND, MSc
  1. Wellness blog
  2. What is Hyperandrogenism?

Hyperandrogenism, also known as androgen excess, is an endocrine (hormonal gland) disorder that is characterized by elevated levels of male hormones (e.g., testosterone). Hyperandrogenism can affect females or males; however, symptoms are more noticeable in female patients. Hyperandrogenism can lead to acne, oily skin, balding, and signs of masculinization, such as facial hair or a deep voice. (13)(32) 

Continue reading below to learn more about the effects of androgen excess in females and strategies to manage the signs and symptoms of hyperandrogenism. 

What are androgens?

Androgens are a group of hormones that regulate the development and maintenance of male characteristics. Androgens may be known as “male hormones,” but don’t be fooled by the name. Both men and women produce androgens, but in differing amounts. Androgens, such as testosterone, are present in much higher levels in males compared to females, and they play an important role in the development of male traits and reproductive activity. (8)

Other androgens include dehydroepiandrosterone (DHEA), DHEA sulfate (DHEA-S) and androstenediol. (10) In females, most androgens are converted into estrogen, a female sex hormone. (3) 

Did you know? Females produce about one-twelfth as much androgen as men. (3)

Effects of androgens in females

In women, androgens play an important role in the hormonal surge that commences puberty, leading to hair growth in the pubic and underarm areas. (14) In adult females, androgens are necessary for estrogen production and have been shown to play a key role in the prevention of bone loss as well as sexual desire and satisfaction. (7)(9)

Androgens are also thought to regulate the function of many organs, including the kidneys, liver, muscles, and the reproductive tract. (24)(28)(30)(33) Androgens may also play a role in regulating body composition, the amount and distribution of body fat and muscle. (29)

Symptoms of hyperandrogenism 

Androgen excess disorders can often go undiagnosed, even though the symptoms may be treated. The signs and symptoms of hyperandrogenism include: 

  • Abdominal obesity
  • Acanthosis nigricans (rough, darkly pigmented areas on the skin)
  • Alopecia (thinning/loss of hair on the head)
  • Deep, hoarse voice 
  • Enlargement of the clitoris
  • High blood pressure (hypertension)
  • Hirsutism (excess body or facial hair)
  • Insulin resistance (cells stop responding to the hormone insulin)
  • Irregular or absent menstrual cycles
  • Low HDL cholesterol (“good cholesterol”) and high LDL cholesterol (“bad cholesterol”)
  • Persistent acne and/or oily skin
  • Weight gain (25) 

Consult with your healthcare provider if you are concerned about hyperandrogenism.

Causes of hyperandrogenism

Androgen excess in females can arise from a variety of medical conditions that affect the endocrine glands such as adrenal glands, ovaries, or pituitary glands. (15)

1. Acromegaly

The pituitary gland is a tiny hormone-secreting gland attached to the brain. It produces hormones and controls other endocrine glands and bodily functions, including growth and reproduction. (19) Acromegaly is a rare, progressive disorder that occurs when the pituitary gland produces too much growth hormone (GH), leading to the excess growth of body tissues over time. (27) Acromegaly occurs in adults and is typically triggered by a noncancerous (benign) tumor of the pituitary gland which increases the release of GH. (21)

hyperandrogenism
Acromegaly usually presents later in life, around 30 to 40 years of age. (2)

The relationship between acromegaly and hyperandrogenism is not well understood. High levels of GH may impair sex hormone binding globulin (SHBG), a protein produced by the liver that attaches to sex hormones ciculating within the body. Low levels of SHBG allows more testosterone to be freely available, potentially increasing the amount of testosterone getting to the body’s tissues. (15)(20)

2. Congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) is an inherited genetic disease that results in abnormal functioning of the adrenal glands. The adrenal glands are two small organs located above the kidneys. (22) The adrenal glands produce a variety of hormones, such as adrenaline and testosterone. Individuals with CAH experience impaired production and regulation of certain hormones, potentially leading to adrenal androgen excess. (23)

3. Cushing’s syndrome

Cushing’s syndrome is an adrenal gland disorder that occurs when the body is exposed to high levels of cortisol (stress hormone) over an extended period of time. This can happen for a number of reasons, including long-term steroid use or excess cortisol production by the body. (16) Since Cushing’s syndrome affects the adrenal glands, serum androgens tend to be elevated or diminished depending on the root cause of Cushing’s syndrome. (4)

4. Polycystic ovary syndrome 

The ovaries are a pair of female glands that are a part of the female reproductive system. Eggs are formed in the ovaries, as well as the female hormones estrogen and progesterone. (18) Polycystic ovary syndrome (PCOS) is a condition that disrupts normal ovarian function and affects hormone levels. It involves infrequent, irregular, or prolonged menstrual periods and often excess androgen levels. (5)(26) 

hyperandrogenism woman holding abdominals
The majority of patients with polycystic ovaries will also have hyperandrogenism. (5)

Management of hyperandrogenism

Managing hyperandrogenism can be complicated as symptoms vary from person to person. Many individuals with hyperandrogenism benefit from making healthy lifestyle changes. Weight management and blood sugar control can be helpful ways to address symptoms of androgen excess. (17) Modest weight loss in individuals with obesity can help to decrease androgen levels and increase SHBG. (6) For some, hyperandrogenism treatment may also involve pharmacological agents or cosmetic interventions.

Acne treatments

A variety of therapies can be used to treat acne. Working with a dermatologist can be beneficial for those with moderate-to-severe acne that doesn’t respond to over-the-counter acne treatments. Consult with your healthcare practitioner to learn more about the best acne treatment options for you. (1) 

Birth control

For women who are not trying to get pregnant, oral contraceptives (birth control pills) can be used to reduce androgens and help address symptoms. (11) 

Combined estrogen-progesterone birth control is usually tried first. This type of birth control typically uses estrogen in the form of ethinyl estradiol. Taking estrogen in this form may lead to an increase in SBGH, which reduces free testosterone. (31) 

Hair removal 

Physical methods of hair removal such as bleaching, electrolysis, laser therapy, shaving, and waxing can be used safely and effectively. Of these methods, only electrolysis and laser therapy can permanently stop hair growth. (12) 

Medications 

Anti-androgen medications block the production of androgens which may help lessen certain symptoms of androgen excess including acne, oily skin, and unwanted hair growth. (12) 

Other medications that are not considered anti-androgenic may also be used to alleviate some symptoms. Insulin resistance is one of the main triggers of hyperandrogenism in females with polycystic ovary syndrome. Metformin, a pharmaceutical agent often used to address type 2 diabetes, helps improve the way the body handles insulin. Normalizing insulin levels may reduce serum androgens and decrease unwanted hair growth and acne. (17)

The bottom line

Androgens are a group of hormones that regulate the development and maintenance of male sex characteristics. They are present in both males and females, although males produce much higher amounts. Hyperandrogenism, or androgen excess, may lead to balding, exaggerated masculine characteristics, severe acne, or unwanted hair growth. Management of hyperandrogenism usually focuses on addressing problematic symptoms. Consult with your integrative healthcare practitioner to learn more about hyperandrogenism and its treatment options. 

Simplify the delivery of whole person care

Create free account I'm a patient
References
  1. ACOG Committee. (2019). Screening and management of the hyperandrogenic adolescent. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/screening-and-management-of-the-hyperandrogenic-adolescent 
  2. Adigun, O. O., Nguyen, M., Fox, T. J., & Anastasopoulou, C. (2021). Acromegaly. In StatPearls. StatPearls Publishing.
  3. “Androgen.” (n.d.). In Encyclopedia Britannica. https://www.britannica.com/science/androgen 
  4. Arnaldi, G., & Martino, M. (2019). Androgens in Cushing’s syndrome. Frontiers of Hormone Research, 53, 77–91.
  5. Ashraf, S., Nabi, M., Rasool, S. ul A., Rashid, F., & Amin, S. (2019). Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: A review. Egyptian Journal of Medical Human Genetics, 20(1), 1–10.
  6. Aubuchon, M., Liu, Y., Petroski, G. F., Thomas, T. R., & Polotsky, A. J. (2016). The impact of supervised weight loss and intentional weight regain on sex hormone binding globulin and testosterone in premenopausal women. Systems Biology in Reproductive Medicine, 62(4), 283–289.
  7. Barrett-Connor, E., Young, R., Notelovitz, M., Sullivan, J., Wiita, B., Yang, H. M., & Nolan, J. (1999). A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. The Journal of Reproductive Medicine, 44(12), 1012–1020.
  8. Clark, R. V., Wald, J. A., Swerdloff, R. S., Wang, C., Wu, F. C. W., Bowers, L. D., & Matsumoto, A. M. (2019). Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex-specific competition in sports, a narrative review. Clinical Endocrinology, 90(1), 15–22.
  9. Davis, S. R., & Wahlin-Jacobsen, S. (2015). Testosterone in women—the clinical significance. The Lancet. Diabetes & Endocrinology, 3(12), 980–992.
  10. Davison, S. L., & Bell, R. (2006). Androgen physiology. Seminars in Reproductive Medicine, 24(2), 71–77.
  11. de Melo, A. S., Dos Reis, R. M., Ferriani, R. A., & Vieira, C. S. (2017). Hormonal contraception in women with polycystic ovary syndrome: Choices, challenges, and noncontraceptive benefits. Open Access Journal of Contraception, 8, 13–23.
  12. Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., … & Norman, R. J. (2012). Epidemiology, diagnosis and management of hirsutism. Human Reproduction Update, 18(2), 146–170.
  13. Filatova, V. A., & Rozhivanov, R. V. (2021). Features of hyperandrogenism in men. Problemy endokrinologii, 67(2), 111–115.
  14. Hiort, O. (2002). Androgens and puberty. Best Practice & Research. Clinical Endocrinology & Metabolism, 16(1), 31–41.
  15. Jain, R., Dutta, D., Shivaprasad, K., Maisnam, I., Ghosh, S., Mukhopadhyay, S., & Chowdhury, S. (2012). Acromegaly presenting as hirsuitism: Uncommon sinister aetiology of a common clinical sign. Indian Journal of Endocrinology and Metabolism, 16(Suppl 2), S297–S299.
  16. Kairys, N., & Schwell, A. (2022). Cushing disease. In StatPearls. StatPearls Publishing.
  17. Kolodziejczyk, B., Duleba, A. J., Spaczynski, R. Z., & Pawelczyk, L. (2000). Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertility and Sterility, 73(6), 1149–1154.
  18. National Cancer Institute. (n.d.-a). “Ovary.” NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ovary 
  19. National Cancer Institute. (n.d.-b). “Pituitary gland.” NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pituitary-gland 
  20. National Library of Medicine. (2020). SHBG blood test. MedlinePlus. https://medlineplus.gov/lab-tests/shbg-blood-test/ 
  21. National Library of Medicine. (2022a). Acromegaly. MedlinePlus. https://medlineplus.gov/ency/article/000321.htm 
  22. National Library of Medicine. (2022b). Adrenal gland disorders. MedlinePlus; National Library of Medicine. https://medlineplus.gov/adrenalglanddisorders.html 
  23. New, M., Yau, M., Lekarev, O., Lin-Su, K., Parsa, A., Pina, C., Yuen, T., & Khattab, A. (2017). Congenital adrenal hyperplasia. Endotext. MDText.com, Inc.
  24. O’Connell, M. D. L., & Wu, F. C. W. (2014). Androgen effects on skeletal muscle: Implications for the development and management of frailty. Asian Journal of Andrology, 16(2), 203–212.
  25. Redmond, G. P. (1998). Androgens and women’s health. International Journal of Fertility and Women’s Medicine, 43(2), 91–97.
  26. Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews, 37(5), 467–520.
  27. Schwartz, R. A. (2020). Gigantism and acromegaly. Medscape. https://emedicine.medscape.com/article/925446-overview 
  28. Shen, M., & Shi, H. (2015). Sex hormones and their receptors regulate liver energy homeostasis. International Journal of Endocrinology, 2015, 294278.
  29. Sowers, M. F., Beebe, J. L., McConnell, D., Randolph, J., & Jannausch, M. (2001). Testosterone concentrations in women aged 25-50 years: Associations with lifestyle, body composition, and ovarian status. American Journal of Epidemiology, 153(3), 256–264.
  30. Tuckerman, E. M., Okon, M. A., Li, T., & Laird, S. M. (2000). Do androgens have a direct effect on endometrial function? An in vitro study. Fertility and Sterility, 74(4), 771–779.
  31. White, T., Jain, J. K., & Stanczyk, F. Z. (2005). Effect of oral versus transdermal steroidal contraceptives on androgenic markers. American Journal of Obstetrics and Gynecology, 192(6), 2055–2059.
  32. Yildiz, B. O. (2006). Diagnosis of hyperandrogenism: Clinical criteria. Best Practice & Research. Clinical Endocrinology & Metabolism, 20(2), 167–176.
  33. Zhao, J. V., & Schooling, C. M. (2020). The role of testosterone in chronic kidney disease and kidney function in men and women: A bi-directional Mendelian randomization study in the UK Biobank. BMC Medicine, 18(1), 122.

Disclaimer

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Prev Next
Back to main wellness blog page

Get more resources for your practice

Protocols
Practice resources
Ingredient library
Webinars

Share

  • Print
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • Pinterest

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for providers and patients alike. Our educational offerings cover a broad range of topics related to whole person care, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Medical Advisory Team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.
Read more

The healthiest cookies you’ll choose today

Our website uses cookies to collect useful information that lets us and our partners support basic functionality, analyze visitor traffic, deliver a better user experience, and provide ads tailored to your interests. Agreeing to the use of cookies is your choice. Learn more

Fullscript leaf icon
Platform
  • What’s new
  • Integrations
  • Testimonials
  • Catalog
Company
  • About us
  • Blog
  • Why Fullscript
  • Careers
  • Partnerships
  • Quality program
Help
  • Book a demo
  • Support Center
  • Provider FAQs
  • Patient FAQ
  • Contact us
  • Security
Developers
  • Engineering at Fullscript
  • API

© Fullscript 2025. All rights reserved.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

  • Privacy Statement
  • Terms of Service
  • Accessibility Policy
  • Customer Support Policy
  • Acceptable Use Policy
  • Privacy Rights Notice
  • Auto Refill Terms and Conditions
  • Consumer Health Data Privacy Notice
American flag - toggles to show american specific contentUS
Canadian flag - toggles to show canada specific contentCanada